| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.6M | -23.1% | +117.2% |
| R&D Expense | $37.7M | +45.8% | +69.8% |
| SG&A Expense | $16.0M | +5.0% | +26.3% |
| Operating Income | -$43.1M | -57.8% | -43.6% |
| Interest Expense | $3K | +0.0% | — |
| Pre-tax Income | -$39.6M | -68.7% | -49.9% |
| Income Tax | -$1.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $83.4M | -17.8% | -44.4% |
| Accounts Receivable | $9.2M | — | — |
| Current Assets | $272.4M | +0.9% | +7.4% |
| Total Assets | $360.3M | -6.3% | +22.8% |
| Current Liabilities | $41.7M | +7.9% | -16.3% |
| Total Liabilities | $52.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $76.0M | — | — |
| Capital Expenditures | $438K | — | — |
| Investing Cash Flow | -$125.8M | — | — |
| Financing Cash Flow | $5.0M | — | — |
| Free Cash Flow | $75.6M | — | — |
| — |
| — |
| Net Income | -$38.3M | -63.3% | -45.1% |
| EPS (Basic) | -$0.65 | -62.5% | -38.3% |
| EPS (Diluted) | -$0.65 | -62.5% | -38.3% |
| +5.2% |
| -14.8% |
| Stockholders' Equity | $308.1M | -8.0% | +32.7% |